- Home
- ETNB vs MLKN Comparison
ETNB vs MLKN Comparison
Compare ETNB & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- MLKN
- Stock Information
- Founded
- ETNB 2018
- MLKN 1905
- Country
- ETNB United States
- MLKN United States
- Employees
- ETNB N/A
- MLKN N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- MLKN Office Equipment/Supplies/Services
- Sector
- ETNB Health Care
- MLKN Consumer Discretionary
- Exchange
- ETNB Nasdaq
- MLKN Nasdaq
- Market Cap
- ETNB 1.0B
- MLKN 1.0B
- IPO Year
- ETNB 2019
- MLKN N/A
- Fundamental
- Price
- ETNB $7.70
- MLKN $16.78
- Analyst Decision
- ETNB Strong Buy
- MLKN
- Analyst Count
- ETNB 9
- MLKN 0
- Target Price
- ETNB $27.25
- MLKN N/A
- AVG Volume (30 Days)
- ETNB 1.5M
- MLKN 471.1K
- Earning Date
- ETNB 05-01-2025
- MLKN 06-25-2025
- Dividend Yield
- ETNB N/A
- MLKN 4.48%
- EPS Growth
- ETNB N/A
- MLKN N/A
- EPS
- ETNB N/A
- MLKN 0.43
- Revenue
- ETNB N/A
- MLKN $3,597,000,000.00
- Revenue This Year
- ETNB N/A
- MLKN $1.97
- Revenue Next Year
- ETNB N/A
- MLKN $3.05
- P/E Ratio
- ETNB N/A
- MLKN $39.33
- Revenue Growth
- ETNB N/A
- MLKN N/A
- 52 Week Low
- ETNB $4.16
- MLKN $15.25
- 52 Week High
- ETNB $11.84
- MLKN $31.73
- Technical
- Relative Strength Index (RSI)
- ETNB 53.47
- MLKN 48.68
- Support Level
- ETNB $7.40
- MLKN $15.77
- Resistance Level
- ETNB $8.92
- MLKN $16.78
- Average True Range (ATR)
- ETNB 0.54
- MLKN 0.53
- MACD
- ETNB 0.13
- MLKN 0.19
- Stochastic Oscillator
- ETNB 53.88
- MLKN 88.33
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract , International Contract & Specialty International & Specialty and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.